The present invention relates generally to the occlusion or modification of tissue openings or appendages and, more specifically, to devices, systems and methods for occluding or otherwise structurally altering such openings and appendages including, for example, left atrial appendages.
The upper chambers of the heart, the atria, have appendages attached to each of them. For example, the left atrial appendage is a feature of all human hearts. The physiologic function of such appendages is not completely understood, but they do act as a filling reservoir during the normal pumping of the heart. The appendages typically protrude from the atria and cover an external portion of the atria. Atrial appendages differ substantially from one to another. For example, one atrial appendage may be configured as a tapered protrusion while another atrial appendage may be configured as a re-entrant, sock-like hole. The inner surface of an appendage is conventionally trabeculated with cords of muscular cardiac tissue traversing its surface with one or multiple lobes.
The atrial appendages appear to be inert while blood is being pumped through them during normal heart function. In other words, the appendages don't appear to have a noticeable effect on blood pumped through them during normal heart function. However, in cases of atrial fibrillation, when the atria go into arrhythmia, blood may pool and thrombose inside of the appendages. Among other things, this can pose a stroke risk when it occurs in the left appendage since the thrombus may be pumped out of the heart and into the cranial circulation once normal sinus rhythm is restored following arrhythmia events.
Historically, appendages have sometimes been modified surgically to reduce the risk imposed by atrial fibrillation. In recent years devices which may be delivered percutaneously into the left atrial appendage have been introduced. The basic function of these devices is to exclude the volume within the appendage with an implant which then allows blood within the appendage to safely thrombose and then to be gradually incorporated into cardiac tissue. This process, coupled with the growth of endothelium over the face of the device, can leave a smooth, endothelialized surface where the appendage is located. In comparison to surgical procedures, devices implanted percutaneously are a less invasive means for addressing the problems associated with the left atrial appendage.
However, due to the wide variability of the ostium size and volume of the left atrial appendage, current implantable devices conventionally include a structure that cannot meet such variability, resulting in inadequate devices for many left atrial appendage anatomies. Further, such implantable devices are substantially limited by the orientation by which they can successfully be deployed. As such it would be advantageous to provide a percutaneous system, method and/or device that addresses, for example, the issues of implant orientation, the variability in sizes and shapes of the left atrial appendage, or all of these, in order to provide high success in left atrial appendage modification. It would also be desirable to provided a device, system and method that enable easy positioning and repositioning of the device relative to the structure being modified or occluded including the positioning (or repositioning) of an occluder portion independent of other components or features of the device.
A variety of features and advantages will be apparent to those of ordinary skill in the art upon reading the description of various embodiments set forth below.
Embodiments of the present invention are directed to various devices, systems and methods of occluding an opening in the tissue of a body. For example, in one embodiment, a medical device system for modifying a left atrial appendage (“LAA”) of a heart is provided. The medical device system includes a sheath and a delivery system. The sheath includes a length and defines a sheath lumen extending through the length of the sheath. The delivery system includes a delivery catheter that extends between a proximal end and a distal end, a handle coupled to the proximal end of the delivery catheter, and a medical device operatively coupled to the handle and coupled to the distal end of the delivery catheter. The medical device includes a hub having a bore that defines an axis, an occluder portion, and an anchor portion. The occluder portion is coupled to the hub and is configured to be moved to an occluder non-deployed position with the occluder portion within a distal portion of the sheath, and the occluder portion configured to be moved to an occluder deployed position upon the sheath being moved proximally relative to the occluder portion. The anchor portion extends between a first end and a second end. The first end is configured to be operatively coupled to the handle and the second end is configured to be coupled to the occluder portion. With this arrangement, upon the occluder portion being in the occluder deployed position, the anchor portion is configured to move relative to the occluder portion between an anchor non-deployed position and an anchor deployed position.
In one embodiment, the second end of the anchor portion is coupled to the occluder portion with a hinge arrangement such that the anchor portion pivots relative to the occluder portion upon the anchor portion being moved between the anchor non-deployed position and the anchor deployed position. In another embodiment, the second end of the anchor portion is pivotably coupled to the occluder portion. In still another embodiment, the first end of the anchor portion is moveable along the axis of the hub to move the anchor portion between the anchor non-deployed position and the anchor deployed position. In another embodiment, the handle includes a plunger shaft that is moveable between a first position and a second position that corresponds with the anchor non-deployed position and the anchor deployed position, respectively.
In another embodiment, the anchor portion includes multiple anchor actuator anus that each extend to a v-extension such that the v-extension includes hooks to engage tissue of the LAA. In another embodiment, the anchor portion includes an anchor zig-zag portion hingably coupled to the occluder portion. In still another embodiment, the occluder portion includes an occluder zig-zag portion and the anchor portion includes an anchor zig-zag portion. In yet another embodiment, the occluder portion includes a tissue growth member extending over a proximal face of the occluder portion and extending over a portion of the anchor portion.
In another embodiment, the distal end of the delivery catheter is threadably connected to the medical device. In another embodiment, the delivery catheter includes an actuator shaft and multiple fingers. The actuator shaft is configured to be actuated by actuation of the handle. Further, the multiple fingers extend distally from the distal end of the delivery catheter such that the multiple fingers extend over the actuator shaft so that the multiple fingers maintain a latched position to the hub. Furthermore, in another embodiment, the medical device is configured to detach from the delivery catheter upon proximal movement of the actuator shaft to a position proximal of the multiple fingers such that the multiple fingers collapse to an inward unlatched position. In yet another embodiment, the sheath includes an imaging device at a distal end of the sheath.
In accordance with another embodiment of the present invention, a medical device for modifying an LAA of a heart. The medical device includes a hub defining an axis, an occluder portion, and an anchor portion. The occluder portion is coupled to the hub. Further, the occluder portion is independently moveable relative to the anchor portion between an occluder non-deployed position and an occluder deployed position. The anchor portion is hingably coupled to the occluder portion such that the anchor portion is pivotable relative to the occluder portion between an anchor non-deployed position and an anchor deployed position upon the occluder portion being in the occluder deployed position.
In one embodiment, the anchor portion includes anchor actuator arms with a portion actuatable substantially along the axis of the hub to move the anchor portion between the anchor non-deployed position and the anchor deployed position. In another embodiment, the anchor portion includes multiple anchor actuator arms each extending to a v-extension such that the extension includes hooks to engage tissue of the LAA. In still another embodiment, the anchor portion includes an anchor zig-zag portion hingably coupled to the occluder portion. In another embodiment, the occluder portion includes an occluder zig-zag portion and the anchor portion includes an anchor zig-zag portion, and the occluder zig-zag portion is hingably coupled to the anchor zig-zag portion.
In another embodiment, the occluder portion includes a tissue growth member that extends over a proximal face of the occluder portion and extends over a portion of the anchor portion. In still another embodiment, the medical device further includes a sheath configured to move the occluder portion between the occluder non-deployed configuration and the occluder deployed configuration, the sheath including an imaging device at a distal end of the sheath.
In accordance with another embodiment of the present invention, a method for modifying an LAA of a heart is provided. The method includes: advancing a medical device coupled to a distal end of a delivery catheter through a sheath positioned in the vasculature and into the LAA of the heart, the medical device including an occluder portion and an anchor portion, the anchor portion coupled to the occluder portion; deploying the occluder portion of the medical device from the sheath in the LAA with the anchor portion maintaining a non-deployed position; and actuating the anchor portion of the medical device between the non-deployed position and a deployed position while the occluder portion of the medical device is deployed.
In another embodiment, the method step of actuating the anchor portion includes pivoting the anchor portion at a hinged coupling between the anchor portion and the occluder portion. In another embodiment, the method step of actuating the anchor portion includes actuating actuator arms of the anchor portion substantially along an axis of the medical device. In still another embodiment, the method step of deploying the occluder portion includes manually withdrawing the sheath from over the occluder portion of the medical device. In another embodiment, the method further includes disengaging the medical device from fingers extending from the distal end of the delivery catheter by proximally moving an actuator shaft from the medical device to collapse the fingers from a hub of the medical device. In still another embodiment, the method further includes imaging the medical device relative to the LAA from a distal end of the sheath.
In accordance with another embodiment of the present invention, a medical device for modifying an LAA of a heart includes an occluder frame and an anchor portion. The occluder frame includes a proximal end and a distal end with the proximal end coupled to a hub. The anchor portion includes a first end and a second end. The second end is hingably coupled to the distal end of the occluder frame and the first end is coupled to a collar arrangement. The collar arrangement is moveable co-axially relative to an axis of the hub to move the anchor portion between an anchor deployed configuration and an anchor non-deployed configuration.
In one embodiment, the anchor portion includes a zig-zag anchor portion. In another embodiment, the zig-zag anchor portion includes tines extending therefrom, the tines configured to engage tissue within the LAA. In another embodiment, the anchor portion includes loop extensions.
In another embodiment, the occluder frame includes a zig-zag occluder portion. In one embodiment, the zig-zag occluder portion includes face struts extending proximally therefrom toward the hub. In another embodiment, the medical device includes a tissue growth member attached to the occluder frame. In one embodiment, the tissue growth member extends distal the distal end of the occluder frame.
In another embodiment, the anchor portion is hingably coupled to the occluder portion to facilitate pivoting the anchor portion relative to the occluder portion between the anchor deployed configuration and the anchor non-deployed configuration. In another embodiment, the anchor portion includes a first hinge arrangement and a second hinge arrangement. In one embodiment, the anchor portion includes a flexure portion distal the zig-zag anchor portion.
In another embodiment, the collar arrangement is a splined sleeve. In another embodiment, the medical device further includes a spring coupled to a proximal end of the hub and is configured to close-off an opening defined in the hub. Such a spring may include a clover configuration. In another embodiment, the medical device further includes a delivery catheter configured to removably couple to the hub. The delivery catheter includes a threaded connector and a collet. The threaded connector is configured to be threaded to the collar arrangement. The collet includes collet fingers extending distally from the collet. The collet fingers are engageable with the hub. The threaded connector, upon being unthreaded from the collar arrangement, is moveable proximally through the collet such that the collet fingers collapse to disengage from the hub.
These various embodiments may include other components, features or acts as will be apparent from the detailed description set forth below. Additionally, other embodiments, configurations and processes are set forth below in the detailed description of the invention.
The foregoing and other advantages of the invention will become apparent upon reading the following detailed description and upon reference to the drawings in which:
Referring first to
As set forth, the occluder portion 24 may include an occluder material or a tissue growth member 28 attached thereto. The tissue growth member 28 may be a porous material, or other cell attaching material or substrate, configured to promote endothelization and tissue growth thereover. The tissue growth member 28 may extend over a proximal side of the medical device 20 and, particularly, over the occluder portion 24 and may extend over a portion of the anchor portion 26 and hinges coupling the anchor portion 26 to the occluder portion 24. As such, due to the shape of the frame components of the occluder portion 24, the tissue growth member 28 may include a proximal face that is generally convex to form an outer surface 40. The tissue growth member 28 may also include an inner surface 42 on its distal side that is generally concave shaped. In one embodiment, the tissue growth member 28 may extend primarily over an outside surface of frame components of the occluder portion 24 with a portion of the tissue growth member 28 extending on both the outside surface and the inside surface of the frame components of the occluder portion 24. In another embodiment, the tissue growth member 28 may extend primarily over both the outside surface and the inside surface of the frame components of the occluder portion 24 of the medical device 20. In another embodiment, the tissue growth member 28 may extend solely over the outside surface of the frame components of the occluder portion 24.
With respect to
The second material layer 32 made of ePTFE effectively prevents the passage of blood, due to the small internodal distance and pore size of the first layer 32A, while the larger internodal distance of other layers (e.g., 32B and 32C) enable tissue in-growth and endothelization to occur. Additionally, the first material layer 30, being formed of a polyurethane foam, enables aggressive growth of tissue from the LAA wall into the tissue growth member 28 at the inside or concave side of the medical device 20. Further, the first material layer 30 provides an exposed shelf 38 on the outer surface 40 around the periphery and distal end portion of the tissue growth member 28, which promotes aggressive fibroblast and tissue growth to further initiate endothelization over the outer surface 40 of the second material layer 32. It is noted that the use of appropriate adhesive materials between the first material layer 30 and the next adjacent layer 32A may also serve to fill in the pores of the next adjacent layer 32A and further inhibit possible flow of blood through the tissue growth member 28. Additional layers of ePTFE may also be included to the second material layer 32 of the tissue growth member 28.
With reference to
The anchor portion 26 may include multiple anchor frame segments that may be interconnected to form the anchor portion 26. The anchor portion 26 may extend between a first end 64 and a second end 66 with anchor actuator arms 68 and an anchor zig-zag portion 70 therebetween. The anchor actuator arms 68 may extend between the first end 64 and the anchor zig-zag portion 70. Each anchor actuator arm 68 may be configured to couple to a collar arrangement or splined sleeve 72 at the first end 64 of the anchor portion 26 such that the anchor actuator arms 68 are coupled as a unit or together via the splined sleeve 72. The splined sleeve 72 may be configured to actuate along an axis 74 of the medical device 20 to move the anchor portion 26 between the anchor deployed position and anchor non-deployed position (not shown), discussed in more detail hereafter.
With reference now to
Each flexure portion 76 of the anchor actuator arms 68 may extend to anchor v-extensions 78 such that the proximal ends of each anchor v-extension 78 may be coupled to proximal ends of adjacent anchor v-extensions 78 (similar to the occluder zig-zag portion 52) to form the anchor zig-zag portion 70. At the interconnection of the proximal ends of the anchor v-extensions 78 or the second end 66 of the anchor portion 26, such proximal ends define an anchor eyelet 80. The anchor eyelet 80 may be sized and configured to hingably couple to a corresponding occluder eyelet 62 of the occluder portion 24, as shown by dotted lines 84 (see
With respect to
With respect to
In another embodiment, the fame components of the occluder portion 24 and the anchor portion 26 may be laser cut from tubular material, rather than a flat sheet. In this embodiment, the frame components may be laser cut, and then heat set to the desired configuration, similar to that shown in
With reference to
Now with reference to
With reference now to
Now with reference to
As depicted in
As set forth, the loader 124 may be mated or inserted into the sheath hub 130 with a snap or click fit via nubs 136 at the distal end of the tube portion 126 and a rib (not shown) within a bore 138 defined in the sheath hub 130. Once the loader 124 is positioned within the sheath hub 130, the delivery catheter 104 may be advanced through a lumen defined longitudinally in the sheath 102 such that the distal end of the delivery catheter 104 moves to a distal portion of the sheath 102 to expose a distal tip of the occluder portion 24 of the medical device 20 from the distal end of the sheath 102. With this arrangement, the distal tip of the occluder portion 24 may be exposed at the distal end of the sheath 102 and provides, due to the occluder material, a cushioned tip 140, without any exposed metal frame members, facilitating an atraumatic entry into the thereby, reducing the potential of effusions in the LAA.
Referring to
With respect to
With reference to
As depicted in
Now turning to
The hooks 86 of the anchor portion 26 may extend both distally and proximally so as to substantially prevent movement of the medical device 20 in both the proximal and distal directions relative to the LAA 5. In one embodiment, the hooks 86 may include an acute angle 88 (
If the physician is dissatisfied with the location or engagement of the medical device in the LAA, the physician may readily disengage the anchor portion 26 from the tissue of the LAA by simply moving the actuator knob 156 in the proximal direction to the first position (
Now referring to
With respect to
Now referring to
Referring hack to
Now with reference to
In this embodiment, the occluder portion 204 is substantially similar to the previous embodiment, except the tissue growth member 210 is attached to an outer surface of the frame components of the occluder portion 204. The tissue growth member 210 of this embodiment may include similar layering of one or more materials as set forth for the tissue growth member described in detail relative to
With reference to
With respect to the anchor frame segments 214, each anchor frame segment 214 may extend between a first end 218 and second end 220 with two actuator arms 222 extending therebetween such that each anchor frame segment 214 may exhibit a “Y” or “V” configuration in the pre-formed state. Each actuator arm 222 may include an anchor hinge aperture 224 at the second end 220 and, at the first end 218, the actuator arm 222 may be coupled to a collar arrangement 226 or splined sleeve, similar to that of the previous embodiment. With this arrangement, the actuator arms 222, as depicted in
Now with reference to
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims.
The present application claims the benefit of U.S. Provisional Application No. 61/553,948, filed on Nov. 1, 2011, and U.S. Provisional Application No. 61/661,799, filed on Jun. 19, 2012. This application also claims benefit to, and is a continuation-in-part of, U.S. patent application Ser. No. 12/818,046, filed on Jun. 17, 2010, which in turn claims benefit to the following U.S. Provisional Patent Applications: U.S. Provisional Application No. 61/345,514, filed on May 17, 2010; U.S. Provisional Application No. 61/325,230, filed on Apr. 16, 2010; U.S. Provisional Application No. 61/320,635, filed on Apr. 2, 2010; U.S. Provisional Application No. 61/294,058, filed on Jan. 11, 2010; and U.S. Provisional Application No. 61/218,018, filed on Jun. 17, 2009. The disclosures of each application listed above are incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
3095877 | Rowan | Jul 1963 | A |
3874388 | King et al. | Apr 1975 | A |
5171259 | Inoue | Dec 1992 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5284488 | Sideris | Feb 1994 | A |
5334217 | Das | Aug 1994 | A |
5425733 | Schmieding | Jun 1995 | A |
5425740 | Hutchinson | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5551341 | Lewis et al. | Sep 1996 | A |
5792165 | Klieman et al. | Aug 1998 | A |
5861003 | Latson et al. | Jan 1999 | A |
5904703 | Gilson | May 1999 | A |
5910154 | Tsugita et al. | Jun 1999 | A |
5992158 | Goddard et al. | Nov 1999 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6174322 | Schneidt | Jan 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6238403 | Greene, Jr. et al. | May 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6355051 | Sisskind et al. | Mar 2002 | B1 |
6371971 | Tsugita et al. | Apr 2002 | B1 |
6398760 | Danby | Jun 2002 | B1 |
6419669 | Frazier et al. | Jul 2002 | B1 |
6436088 | Frazier et al. | Aug 2002 | B2 |
6458100 | Roue et al. | Oct 2002 | B2 |
6488689 | Kaplan et al. | Dec 2002 | B1 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6561969 | Frazier et al. | May 2003 | B2 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6651557 | Costin et al. | Nov 2003 | B1 |
6652555 | VanTassel et al. | Nov 2003 | B1 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6666861 | Grabek | Dec 2003 | B1 |
6689150 | VanTassel et al. | Feb 2004 | B1 |
6702825 | Frazier et al. | Mar 2004 | B2 |
6706065 | Langberg et al. | Mar 2004 | B2 |
6712804 | Roue et al. | Mar 2004 | B2 |
6730108 | Van Tassel et al. | May 2004 | B2 |
6746472 | Frazier et al. | Jun 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6949113 | Van Tassel et al. | Sep 2005 | B2 |
6979344 | Jones et al. | Dec 2005 | B2 |
6994092 | van der Burg et al. | Feb 2006 | B2 |
7011671 | Welch | Mar 2006 | B2 |
7014645 | Greene, Jr. et al. | Mar 2006 | B2 |
7025756 | Frazier et al. | Apr 2006 | B2 |
7044134 | Khairkhahan et al. | May 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7115110 | Frazier et al. | Oct 2006 | B2 |
7128073 | van der Burg et al. | Oct 2006 | B1 |
7152605 | Khairkhahan et al. | Dec 2006 | B2 |
7169164 | Borillo et al. | Jan 2007 | B2 |
7192439 | Khairkhahan et al. | Mar 2007 | B2 |
7226458 | Kaplan et al. | Jun 2007 | B2 |
7293562 | Malecki et al. | Nov 2007 | B2 |
7597704 | Frazier et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7717937 | Wahr et al. | May 2010 | B2 |
7727189 | Van Tassel et al. | Jun 2010 | B2 |
7780645 | Jones | Aug 2010 | B2 |
7842054 | Greene, Jr. et al. | Nov 2010 | B2 |
8142470 | Quinn et al. | Mar 2012 | B2 |
8740934 | McGuckin, Jr. | Jun 2014 | B2 |
9351716 | Miles et al. | May 2016 | B2 |
20010003161 | Vardi et al. | Jun 2001 | A1 |
20010037141 | Yee et al. | Nov 2001 | A1 |
20020022860 | Borillo et al. | Feb 2002 | A1 |
20020026094 | Roth | Feb 2002 | A1 |
20020026217 | Baker et al. | Feb 2002 | A1 |
20020062130 | Jugenheimer et al. | May 2002 | A1 |
20020177855 | Greene, Jr. et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030014075 | Rosenbluth et al. | Jan 2003 | A1 |
20030055455 | Yang et al. | Mar 2003 | A1 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20030125790 | Fastovsky et al. | Jul 2003 | A1 |
20030171739 | Murphy et al. | Sep 2003 | A1 |
20030181942 | Sutton et al. | Sep 2003 | A1 |
20030187474 | Keegan et al. | Oct 2003 | A1 |
20030191526 | Van Tassel et al. | Oct 2003 | A1 |
20030195555 | Khairkhahan et al. | Oct 2003 | A1 |
20030199923 | Khairkhahan et al. | Oct 2003 | A1 |
20030204203 | Khairkhahan et al. | Oct 2003 | A1 |
20030212432 | Khairkhahan et al. | Nov 2003 | A1 |
20030220667 | van der Burg et al. | Nov 2003 | A1 |
20040034366 | van der Burg et al. | Feb 2004 | A1 |
20040049224 | Buehlmann et al. | Mar 2004 | A1 |
20040098028 | Martinez | May 2004 | A1 |
20040122467 | VanTassel et al. | Jun 2004 | A1 |
20040127935 | VanTassel et al. | Jul 2004 | A1 |
20040153120 | Seifert et al. | Aug 2004 | A1 |
20040215230 | Frazier et al. | Oct 2004 | A1 |
20040254594 | Alfaro | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040267191 | Gifford, III et al. | Dec 2004 | A1 |
20050004652 | van der Burg et al. | Jan 2005 | A1 |
20050033409 | Burke et al. | Feb 2005 | A1 |
20050038470 | Van der Burg et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050049573 | Van Tassel et al. | Mar 2005 | A1 |
20050049681 | Greenhalgh et al. | Mar 2005 | A1 |
20050060017 | Fischell et al. | Mar 2005 | A1 |
20050065589 | Schneider et al. | Mar 2005 | A1 |
20050075665 | Brenzel et al. | Apr 2005 | A1 |
20050090860 | Paprocki | Apr 2005 | A1 |
20050113861 | Corcoran et al. | May 2005 | A1 |
20050149173 | Hunter et al. | Jul 2005 | A1 |
20050177182 | van der Burg et al. | Aug 2005 | A1 |
20050192616 | Callister et al. | Sep 2005 | A1 |
20050192627 | Whisenant et al. | Sep 2005 | A1 |
20050222533 | Chanduszko et al. | Oct 2005 | A1 |
20050234540 | Peavey et al. | Oct 2005 | A1 |
20050234543 | Glaser et al. | Oct 2005 | A1 |
20050251144 | Wilson et al. | Nov 2005 | A1 |
20050256532 | Nayak et al. | Nov 2005 | A1 |
20050267524 | Chanduszko | Dec 2005 | A1 |
20060000443 | Kado et al. | Jan 2006 | A1 |
20060004433 | Greenberg et al. | Jan 2006 | A1 |
20060009798 | Callister | Jan 2006 | A1 |
20060009800 | Christianson et al. | Jan 2006 | A1 |
20060036282 | Wahr et al. | Feb 2006 | A1 |
20060052816 | Bates et al. | Mar 2006 | A1 |
20060122646 | Corcoran et al. | Jun 2006 | A1 |
20060149299 | Greene et al. | Jul 2006 | A1 |
20060149307 | Durgin | Jul 2006 | A1 |
20060149314 | Borillo et al. | Jul 2006 | A1 |
20060155323 | Porter et al. | Jul 2006 | A1 |
20060206148 | Khairkhahan et al. | Sep 2006 | A1 |
20060217761 | Opolski | Sep 2006 | A1 |
20060229668 | Prestezog et al. | Oct 2006 | A1 |
20060276839 | McGuckin, Jr. | Dec 2006 | A1 |
20070027456 | Gartner et al. | Feb 2007 | A1 |
20070066993 | Kreidler | Mar 2007 | A1 |
20070073247 | Ewaschuk | Mar 2007 | A1 |
20070083230 | Javois | Apr 2007 | A1 |
20070083232 | Lee | Apr 2007 | A1 |
20070088388 | Opolski et al. | Apr 2007 | A1 |
20070112382 | Thill et al. | May 2007 | A1 |
20070123934 | Whisenant et al. | May 2007 | A1 |
20070129753 | Quinn et al. | Jun 2007 | A1 |
20070129757 | Armstrong | Jun 2007 | A1 |
20070135826 | Zaver et al. | Jun 2007 | A1 |
20070149995 | Quinn et al. | Jun 2007 | A1 |
20070167981 | Opolski | Jul 2007 | A1 |
20070173885 | Cartier et al. | Jul 2007 | A1 |
20070179527 | Eskuri et al. | Aug 2007 | A1 |
20070179583 | Goetzinger et al. | Aug 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070198059 | Patel et al. | Aug 2007 | A1 |
20070213766 | Ravikumar | Sep 2007 | A1 |
20070237720 | Padilla et al. | Oct 2007 | A1 |
20070270891 | McGuckin | Nov 2007 | A1 |
20070276415 | Kladakis et al. | Nov 2007 | A1 |
20080039929 | Davis et al. | Feb 2008 | A1 |
20080119891 | Miles et al. | May 2008 | A1 |
20080215086 | Olsen et al. | Sep 2008 | A1 |
20090025820 | Adams | Jan 2009 | A1 |
20090069840 | Hallisey | Mar 2009 | A1 |
20090099596 | McGuckin et al. | Apr 2009 | A1 |
20090105747 | Chanduszko et al. | Apr 2009 | A1 |
20090112249 | Miles et al. | Apr 2009 | A1 |
20090171386 | Amplatz et al. | Jul 2009 | A1 |
20090192518 | Golden | Jul 2009 | A1 |
20090299338 | di Palma | Dec 2009 | A1 |
20090318948 | Linder et al. | Dec 2009 | A1 |
20100191279 | Kassab et al. | Jul 2010 | A1 |
20100228279 | Miles et al. | Sep 2010 | A1 |
20100228285 | Miles et al. | Sep 2010 | A1 |
20100234878 | Hruska et al. | Sep 2010 | A1 |
20100324585 | Miles et al. | Dec 2010 | A1 |
20100324586 | Miles et al. | Dec 2010 | A1 |
20100324587 | Miles et al. | Dec 2010 | A1 |
20100324588 | Miles et al. | Dec 2010 | A1 |
20110022079 | Miles et al. | Jan 2011 | A1 |
20110046658 | Connor et al. | Feb 2011 | A1 |
20110054515 | Bridgeman et al. | Mar 2011 | A1 |
20110208233 | McGuckin, Jr. et al. | Aug 2011 | A1 |
20120316584 | Miles et al. | Dec 2012 | A1 |
20130178889 | Miles et al. | Jul 2013 | A1 |
20140364941 | Edmiston et al. | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
2627408 | May 2008 | CA |
102006056283 | Jun 2008 | DE |
1266630 | Dec 2002 | EP |
1358850 | Nov 2003 | EP |
1523957 | Apr 2005 | EP |
1741393 | Jan 2007 | EP |
2008536620 | Sep 2008 | JP |
2010500917 | Jan 2010 | JP |
9933402 | Jul 1999 | WO |
0027292 | May 2000 | WO |
0193920 | Dec 2001 | WO |
02071977 | Sep 2002 | WO |
03028802 | Apr 2003 | WO |
2004045393 | Jun 2004 | WO |
2004100803 | Nov 2004 | WO |
2005053547 | Jun 2005 | WO |
2005099365 | Oct 2005 | WO |
2005033641 | Mar 2006 | WO |
2006047748 | May 2006 | WO |
2007054116 | May 2007 | WO |
2007147145 | Dec 2007 | WO |
2008150346 | Dec 2008 | WO |
2010081033 | Jul 2010 | WO |
2010148246 | Dec 2010 | WO |
Entry |
---|
Office Action and English Translation issued in JP2012-516313 on Mar. 25, 2014. |
International Search Report dated Feb. 7, 2013 for International Application No. PCT/US2012/063074 (5 pages). |
International Search Report dated Apr. 26, 2010 for International Application No. PCT/US2010/020549 (7 pages). |
International Search Report dated May 7, 2010, for International Application No. PCT/US2010/020547 (4 pages). |
International Search Report dated May 6, 2010 International Application No. PCT/US2010/020539 (5 pages). |
International Search Report dated Jun. 15, 2009, for International Application No. PCT/US2008/080374 (7 pages). |
Office Action and English Translation issued in JP2012-516313 on Mar. 25, 2914. |
English Abstract and English machine translation of the Specification and Claims of DE102006056283, Jun. 5, 2008. |
Number | Date | Country | |
---|---|---|---|
20130178889 A1 | Jul 2013 | US |
Number | Date | Country | |
---|---|---|---|
61553948 | Nov 2011 | US | |
61661799 | Jun 2012 | US | |
61345514 | May 2010 | US | |
61325230 | Apr 2010 | US | |
61320635 | Apr 2010 | US | |
61294058 | Jan 2010 | US | |
61218018 | Jun 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12818046 | Jun 2010 | US |
Child | 13666612 | US |